FCF Yield

Align Technology’s current free cash flow (FCF) yield of 4.3% means that for every $100 invested in the stock, the company generates $4.30 in cash after covering operating expenses and capital spending — a measure of how much cash return an investor gets relative to the share price.

Among Healthcare sector peers, this yield sits above the median of 3.4% and places the stock in the 56th percentile, indicating a slightly higher cash return than half of its competitors. The trend data is not available, with year-over-year and quarter-over-quarter changes both reported as N/A, so no direction can be inferred from recent movements. The combination of a 4.3% yield that is above the sector median but lacking a trend history suggests a moderate cash‑return profile without clear momentum — neither a deep value opportunity nor a deterioration signal. This metric supports the overall NEUTRAL verdict because the yield is only modestly above the sector median and the absence of trend data provides no catalyst to upgrade or downgrade the stock.

Frequently Asked Questions

Closest Sector Peers